These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25909213)

  • 21. Adiponectin: a key adipocytokine in metabolic syndrome.
    Okamoto Y; Kihara S; Funahashi T; Matsuzawa Y; Libby P
    Clin Sci (Lond); 2006 Mar; 110(3):267-78. PubMed ID: 16464169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin in health and disease.
    Oh DK; Ciaraldi T; Henry RR
    Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Adiponectin in Maintaining Metabolic Homeostasis.
    Adiyaman SC; Ozer M; Saydam BO; Akinci B
    Curr Diabetes Rev; 2020; 16(2):95-103. PubMed ID: 31267874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin and its role in the obesity-induced insulin resistance and related complications.
    Haluzík M; Parízková J; Haluzík MM
    Physiol Res; 2004; 53(2):123-9. PubMed ID: 15046547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adiponectin system in insulin resistance.
    Caselli C
    Mol Genet Metab; 2014 Nov; 113(3):155-60. PubMed ID: 25242063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin receptors: a review of their structure, function and how they work.
    Yamauchi T; Iwabu M; Okada-Iwabu M; Kadowaki T
    Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):15-23. PubMed ID: 24417942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adiponectin and atherosclerosis].
    Haluzíková D; Roubícek T; Haluzík M
    Vnitr Lek; 2007 Apr; 53(4):359-63. PubMed ID: 17578166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.
    Fortuño A; Rodríguez A; Gómez-Ambrosi J; Frühbeck G; Díez J
    J Physiol Biochem; 2003 Mar; 59(1):51-60. PubMed ID: 12903905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease.
    Méndez-Sánchez N; Chavez-Tapia NC; Zamora-Valdés D; Uribe M
    Mini Rev Med Chem; 2006 Jun; 6(6):651-6. PubMed ID: 16787375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin, obesity, and cardiovascular disease.
    Fasshauer M; Paschke R; Stumvoll M
    Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin as a potential biomarker of vascular disease.
    Ebrahimi-Mamaeghani M; Mohammadi S; Arefhosseini SR; Fallah P; Bazi Z
    Vasc Health Risk Manag; 2015; 11():55-70. PubMed ID: 25653535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
    Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
    J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin, the controversial hormone.
    Garaulet M; Hernández-Morante JJ; de Heredia FP; Tébar FJ
    Public Health Nutr; 2007 Oct; 10(10A):1145-50. PubMed ID: 17903323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease].
    Palomer X; Pérez A; Blanco-Vaca F
    Med Clin (Barc); 2005 Mar; 124(10):388-95. PubMed ID: 15766512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
    Kawano J; Arora R
    J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.